Viracta Therapeutics (VIRX) Appoints Michael Faerm as CFO May 14, 2024 07:01AM
Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer May 14, 2024 07:00AM
Syndax Pharmaceuticals (SNDX) names Steven Closter as Chief Commercial Officer Mar 18, 2024 07:03AM
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer Mar 18, 2024 07:00AM
Delix Presents Interim Data From Phase I Trial of Novel Neuroplastogen at ACNP Annual Meeting Dec 6, 2023 08:00AM
View Older Stories

Apr 12, 2023 04:30PM Gain Therapeutics (GANX) Appoints C. Evan Ballantyne as CFO
Apr 12, 2023 04:30PM Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
Apr 12, 2023 04:30PM Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
Nov 10, 2022 08:00AM Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Aug 18, 2022 06:17PM Clinovo taps Life Sciences executive Nandish Poluru as its next Chief Executive Officer
May 18, 2022 08:00AM ProJenX Names Life Sciences Industry Veteran Stan E. Abel as CEO
Feb 3, 2022 04:04PM Syndax Pharmaceuticals (SNDX) Announces CEO Transition
Feb 3, 2022 04:01PM Syndax Pharmaceuticals Announces Transition of Michael A. Metzger to Chief Executive Officer; Briggs W. Morrison, M.D., to Assume Role of President, Head of Research & Development
Jan 25, 2022 08:30AM Immunovant Appoints Mark Levine as Chief Legal Officer
Aug 17, 2021 07:00AM OncXerna Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
Feb 27, 2019 08:00AM Neurogene Appoints Industry Leaders Dr. Sukumar Nagendran and Dr. Serge Stankovic to Board of Directors
Sep 25, 2018 04:12PM Syndax Pharmaceuticals (SNDX) Appoints Jennifer Jarrett and William Meury to Board Succeeding Luke Evnin Ph.D. and Henry Chen
Sep 25, 2018 04:05PM Syndax Announces Changes to its Board of Directors
Apr 12, 2018 08:00AM Spero Therapeutics Appoints Ian A. Critchley, Ph.D., as Head of Clinical Microbiology
May 31, 2017 08:00AM Allergan to Present Data from its Anti-Infectives Portfolio at ASM Microbe 2017 in New Orleans
Aug 4, 2016 04:05PM Adamas Reports Second Quarter 2016 Financial Results
May 10, 2016 07:30AM Allergan Reports Strong First Quarter 2016 Continuing Operations Performance with 48% Increase in Net Revenue to $3.8 Billion and 15% Growth in Non-GAAP Diluted EPS to $3.04
Apr 21, 2016 07:00AM Helocyte Announces Corporate and Clinical Milestones
Apr 8, 2016 07:30AM Allergan Reinforces Commitment to Anti-Infective Innovation with 20 Abstracts Highlighted at ECCMID 2016
Feb 22, 2016 07:30AM Allergan Reports Exceptional Fourth Quarter 2015 Continuing Operations Performance with 74% Increase in Net Revenue to $4.2 Billion and 33% Growth in Non-GAAP Diluted EPS to $3.41
Sep 28, 2015 07:00AM ZIOPHARM Appoints Scott Tarriff to Its Board of Directors
Sep 10, 2015 07:00AM Allergan Announces Agreement with Amneal Related to NAMENDA XR® Patent Litigation
Sep 2, 2015 07:15AM Allergan Announces FDA Approval of Updated Label for TEFLARO® (ceftaroline fosamil)
Sep 1, 2015 08:00AM Eleven Biotherapeutics Announces Promotions of Gary Sternberg, MD, MBA to Chief Business Officer and John McCabe, CPA to Senior Vice President, Finance
Aug 6, 2015 07:00AM Allergan Reports Exceptional Second Quarter 2015 Performance with 116% Increase in Net Revenue to $5.76 Billion and 29% Growth in Non-GAAP EPS to $4.41
Jun 24, 2015 04:01PM Eleven Biotherapeutics (EBIO) CFO Resigns
Jun 24, 2015 04:00PM Eleven Biotherapeutics Announces Executive Change
Jun 17, 2015 07:03AM Agenus (AGEN) Appoints New CFO
Jun 17, 2015 07:00AM Agenus Appoints C. Evan Ballantyne as Chief Financial Officer
Jun 15, 2015 04:33PM Health Connexions™ joins hands with FDASmart to help emerging science accelerate success with US FDA regulatory compliance and registrations
Jun 15, 2015 08:00AM Syndax Appoints Dr. Briggs W. Morrison as Chief Executive Officer and Michael A. Metzger as President and Chief Operating Officer
Jun 2, 2015 07:00AM ZIOPHARM Announces Caesar J. Belbel, Chief Legal Officer, Appointed Chief Operating Officer
Jun 2, 2015 07:00AM ZIOPHARM Announces Caesar J. Belbel, Chief Legal Officer, Appointed Chief Operating Officer
May 11, 2015 06:30AM Actavis Reports Exceptional Performance in First Quarter 2015 with 59% Increase in Net Revenue to $4.2 Billion and 23% Growth in Non-GAAP EPS to $4.30
May 5, 2015 04:01PM Ironwood Pharmaceuticals Provides First Quarter 2015 Investor Update
Apr 13, 2015 07:00AM Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer
Mar 11, 2015 10:29AM Cortendo Reports Results and Activities for the Fourth Quarter and Full Year 2014
Sep 20, 2012 07:14AM FDA Approves AEROSPAN, Forest Labs (FRX) Assumes Development and Commercialization
Jul 17, 2012 12:50PM Icahn Highlights Qualifications on Board Nominees in Response to Forest Labs (FRX)
Jul 16, 2012 07:01AM Forest Labs (FRX) Sends Out Shareholder Letter; Recommends Voting for 'Qualified' Director Slate
Jul 11, 2012 06:22AM Forest Labs' (FRX) CEO Soloman Sends Letter to Icahn; Calls Board Nominations 'Puzzling'
Apr 13, 2011 04:41PM Forest Labs (FRX) Completes Clinical Data Acquisition
Apr 12, 2011 09:24AM Forest (FRX) Reports Successful Tender for Clinical Data (CLDA)
Apr 4, 2011 08:55AM Forest Labs (FRX) Extends Deadline for Acquisition of Clinical Data (CLDA); Amends Merger Agreement
Mar 8, 2011 08:34AM Forest (FRX) Commences Tender for Clinical Data (CLDA)
Feb 23, 2011 08:22AM Needham & Company Maintains a 'Hold' on Forest Laboratories (FRX); Clinical Data Deal Brings Solid SSRI Entrant Viibryd Though “Too Little Too Late” & Undifferentiated Profile Concerns
Feb 23, 2011 08:05AM Wedbush Downgrades Clinical Data (CLDA) to Neutral; Forest Buying CLDA for $30 Plus CVR,
View Older Stories